P-128 is under clinical development by GangaGen Biotechnologies and currently in Phase II for Staphylococcus aureus Infections.

Aux Terroirs is recalling certain Fromagerie des Grondines cheeses because of the possible presence of E. coli and Staphylococcus aureus. According to the ...

Promising clinical results observed in the first 88 patients evaluated so far, confirming the safety and an important clinical benefit for patients Control of the infection at 3 months for ...

While occasional delays in laundry might seem harmless, health experts warn that consistently postponing wash day can lead to ...

APSA-02 is under clinical development by Armata Pharmaceuticals and currently in Phase II for Bacteremia. According to GlobalData, Phase II drugs for Bacteremia have a 66% phase transition success ...

PHAXIAM Therapeutics (Euronext: PHXM - FR0011471135), a biopharmaceutical company developing innovative treatments for severe and resistant bacterial infections, today announced the clinical results ...

At least 41 people in Preah Sihanouk town were hospitalised on December 26 after eating sandwiches contaminated with two ...

Staphylococcus aureus (S. aureus) is a major cause of skin and soft tissue infections that can sometimes lead to sepsis and toxic shock syndrome.The microbe poses a significant threat to public ...

Research shows that neglected bath towels can become breeding grounds for various harmful organisms, potentially compromising ...

Pune: Doctors have reported a steady increase in infections resistant to antibiotics among children in the city, indicating that humans without the us.